We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alkemy Capital Investments Plc | LSE:ALK | London | Ordinary Share | GB00BMD6C023 | ORD GBP0.02 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 10.50 | 11.41% | 102.50 | 100.00 | 105.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 102.50 | 92.00 | 92.00 | 96,800 | 15:52:40 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 0 | -2.65M | -0.3239 | -3.16 | 8.37M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/2/2024 | 07:00 | UK RNS | Alkemy Capital Investments PLC Change of Adviser |
| 30/1/2024 | 14:20 | ALNC |  TRADING UPDATES: Lexington completes Bothaville drilling phase |
| 30/1/2024 | 07:00 | UK RNS | Alkemy Capital Investments PLC MOU with Syrah for UK’s first Graphite.. |
| 18/1/2024 | 14:34 | UKREG | 0OIR Alk Completes First Part Of Phase 1 Trial With Peanut Slit-tablet |
| 18/1/2024 | 14:34 | UKREG | 0OIR Alk Afslutter Første Del Af Fase 1-studie Med Peanuttablet |
| 18/1/2024 | 14:28 | ALNC | IN BRIEF: Alkemy Capital optimistic on lithium process outlook |
| 18/1/2024 | 07:00 | UKREG | Alkemy Capital Investments PLC Corporate Update |
| 04/1/2024 | 13:00 | UKREG | 0OIR Alk To Become Sole Manufacturer And Distributor Of Skin Antigen Test.. |
| 02/1/2024 | 17:00 | UKREG | Alkemy Capital Investments PLC Correction - Oversubscribed Placing |
| 20/12/2023 | 09:45 | UKREG | 0OIR Alk -- Financial Calendar For The 2024 Financial Year |
1 Year Alkemy Capital Investments Chart |
Intraday Alkemy Capital Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
